Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK14 | Q16539 | 20/20 | 0.76 |
| ▸ | MAPK11 | Q15759 | 3/20 | 0.54 |
| ▸ | MAPK13 | O15264 | 2/20 | 0.54 |
| ▸ | MAPK12 | P53778 | 2/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4732036 | 0.92 | MAPK14 (0.64) | MAPK14MAPK11MAPK13MAPK12 | |
| SCHEMBL6864369 | 0.92 | MAPK14 (0.71) | MAPK14MAPK11MAPK13MAPK12 | |
| SCHEMBL6668998 | 0.87 | MAPK14 (1.00) | MAPK14MAPK11MAPK13MAPK12 | |
| SCHEMBL4783647 | 0.86 | MAPK14 (0.59) | MAPK14MAPK11MAPK13MAPK12 | |
| SCHEMBL14201925 | 0.84 | MAPK14 (0.57) | MAPK14MAPK11MAPK13MAPK12 | |
| SCHEMBL4732500 | 0.82 | MAPK14 (0.58) | MAPK14MAPK11MAPK13MAPK12 | |
| SCHEMBL14203884 | 0.80 | MAPK14 (0.60) | MAPK14MAPK11MAPK13MAPK12 | |
| SCHEMBL16573718 | 0.77 | MAPK14 (0.72) | MAPK14MAPK11 | |
| SCHEMBL6666576 | 0.77 | MAPK14 (0.52) | MAPK14MAPK11MAPK13MAPK12 | |
| SCHEMBL6667548 | 0.76 | MAPK14 (0.61) | MAPK14MAPK11MAPK13MAPK12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008053158-A1 | INHIBITORS OF P38 MITOGEN-ACTIVATED PROTEIN KINASE | CHROMA THERAPEUTICS LTD. (GB) | 2008-05-08 | — | — | WO | disclosed |
| WO-2008053158-A1 | INHIBITORS OF P38 MITOGEN-ACTIVATED PROTEIN KINASE | CHROMA THERAPEUTICS LTD. (GB) | 2008-05-08 | — | — | WO | disclosed |